HFA Premium Access

Why treatment with natriuretic peptide analogs failed to fulfill our expectations? - receptor expression and function in a failing heart.

Congress Session

About the speaker

Doctor Katarzyna Kodziszewska

Royal Brompton and Harefield Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Novel drugs in heart failure: what's on the horizon?

Speaker: Professor C. Maack (Wuerzburg, DE)

Thumbnail

Effects of serelaxin on a systolic cardiac dysfunction induced by isoproterenol in mice with increased cardiac aldosterone

Speaker: Doctor G. Billebeau (Paris, FR)

Thumbnail

ORM-3819 promotes cardiac contractility on a dual mechanism of action: troponin-C dependent calcium sensitization is supported by selective PDE III inhibition

Speaker: Doctor L. Nagy (Debrecen, HU)

Thumbnail

Vepoloxamer (purified poloxamer-188) improves LV function, limits cardiomyocyte calcium overload and restores integrity of calciu cycling proteins in myocardium of dogs with advanced heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Thumbnail

Targeting HDACs in heart failure.

Thumbnail

Access the full session

Novel drugs - how do they work?

Speakers: Doctor K. Kodziszewska, Professor C. Maack, Doctor G. Billebeau, Doctor L. Nagy, Professor H. Sabbah
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk